%0 Case Reports
%T Novel homozygous mutation in SCNN1A gene in an Iranian boy with PHA1B.
%A Saffari F
%A Bahadoran E
%A Homaei A
%A Moghbelinejad S
%J J Pediatr Endocrinol Metab
%V 0
%N 0
%D 2024 Jul 5
%M 38963175
%F 1.52
%R 10.1515/jpem-2023-0505
%X <B>OBJECTIVE: </B>Pseudohypoaldosteronism type 1 (PHA1) has two genetically distinct variants, including renal and systemic forms. Systemic PHA type I (PHA1B) has varying degrees of clinical presentation and results from mutations in genes encoding subunits of the epithelial sodium channel (ENaC) including the alpha, beta, and gamma subunits. To date, about 45 variants of PHA1B have been identified.<BR><B>METHODS: </B>We report a boy with PHA1B, who presented with vomiting, lethargy, and poor feeding due to salt wasting six days after birth. The patient had electrolyte imbalances. A novel SCNN1A (sodium channel epithelial subunit alpha) gene mutation, NM_001038.6:c.1497G>C, with an autosomal recessive pattern, was identified by whole exosome sequencing. This variant was inherited as a homozygote from both heterozygous parents.<BR><B>CONCLUSIONS: </B>PHA should be considered in neonates with hyponatremia and hyperkalemia. This case report presents a patient with a novel mutation in SCNN1A that has not been previously reported. Long-term follow-up of identified patients to understand the underlying phenotype--genotype link is necessary.